Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Water-Soluble Tomato Concentrate, a Potential Antioxidant
Supplement, Can Attenuate Platelet Apoptosis and Oxidative
Stress in Healthy Middle-Aged and Elderly Adults: A
Randomized, Double-Blinded, Crossover Clinical Trial
https://www.mdpi.com/2072-6643/14/16/3374/pdf?version=1660736023
5. Conclusions
The results showed that four weeks of WSTC supplementation could attenuate oxidative stress and platelet apoptosis in healthy middle-aged and elderly adults. In addition,
our study further added evidence that WSTC could safely and effectively reduce platelet
aggregation and activation in healthy middle-aged and elderly adults. Therefore, our
current results indicate that the beneficial effects of WSTC may have a potential role in the
early prevention of ASCVD.
"These findings are consistent with Xiao et al., who revealed
that quercetin, one component of WSTC, inhibited stored platelet apoptosis by increasing
the Bcl-2/Bax ratio in a concentration-dependent manner [45]. Notably, nutrients promote
apoptosis in cancer cells, but chlorogenic acid, rutin and polyphenols (e.g., resveratrol and
curcumin) have to exert an antiapoptotic effect by inhibiting oxidative stress in normal cell
lines [46,47]. Whether one or more components of WSTC or only the mixture contribute
to protecting platelet apoptosis is worthy of further study."
Apoptosis
Apoptosis is the process of programmed cell death. It is used during early development to eliminate unwanted cells; for example, those between the fingers of a developing hand. In adults, apoptosis is used to rid the body of cells that have been damaged beyond repair. Apoptosis also plays a role in preventing cancer. If apoptosis is for some reason prevented, it can lead to uncontrolled cell division and the subsequent development of a tumor.
https://www.genome.gov/genetics-glossary/apoptosis#:~:text=Apoptosis%20is%20the%20process%20of,a%20role%20in%20preventing%20cancer.
Further study.
Always further study. WSTC seems to create a monkey puzzle of differing effects. Do these studies move us closer to mass commercialisation ?
Any/all study(s) for WSTC, including this one, that shows "beneficial effects" does, IMO, help us to get closer to "mass commercialisation"
Don't get me wrong gix, The growing list of health benefits is awesome in comparison to the single one that was the aim of the EFSA approval application all those years ago. However, to be effective, a promotion has to be focussed, so, in that respect alone, I feel that brand owners may wait rather than miss out on the complete list. Obviously, I can't fathom their thinking, surely all these studies put Fruitflow on more agendas.
Hope so.
Alf
Totally agree, so do these peeps:
https://supplementpolice.com/fruitflow-plus/
FruitFlow Plus Verdict
FruitFlow Plus is a somewhat enigmatic supplement that perhaps sufferers from unintentionally confusing marketing and overly-complex explanations of how it works and what it does. The competitive nature of the health supplement market has made it common for health supplement manufacturers to provide elaborate and often confusing details on the effects of their products when perhaps a more simple explanation would suffice.
In short, FruitFlow Plus is essentially super-concentrated tomato extract mixed with omega-3 fish oil, and has been clinically proven to deliver a protective effect against heart disease. It’s also cost effective and time effective, as you’d likely need to consume around twenty kilograms of raw tomato to gain the same nutritional boost.
If you’re looking for an effective heart health supplement, FruitFlow+ is a great choice, although they could probably benefit from simplifying their marketing methods.
Alfista, I know what you mean but Provexis has no control over what other companies/hospitals/universities decide to do wrt clinical studies/trials on wstc. It's not even clear how much input By-Health had on this one other than supplying the tablets and being one of three funders. But..... if it helps By-Health in any way towards the new permitted health function claim in China then we will all be happy.
With all of these new developments has anyone tried to work out what the value of our IP and Patents is?
I am fairly certain that if someone wanted to buy the IP, it would cost significantly more than £19M (the current market cap of the Company). To an extent, that merely shows how ineffective the marketing of this product has been and just backs up some of the comments below.
Healthy China 2030 highlighted platelet aggregation as a major health risk to be addressed. BH are addressing that with FF at significant cost to them. Other companies will look to use FF in their products to demonstrate how they are contributing to Healthy China 2030. All these studies will help BH to clearly demonstrate to the government and their customers how FF addresses that health risk. Once approved, I hope the government is right behind them, helping them promote it and helping them to get it into the healthcare system.
I've got no doubt that By Health will take the ingredient forwards in a selection of product formats, in that way the presence of multiple health claims may turn out to be beneficial. For the rest of the world, how many other health products is anyone aware of that have been studied and reported on as possessing such wide variety of established and further potential applications?
Overall, I'm glad that such academic interest is ongoing so many years after Prof. Asim's initial discovery, and Prof. Niamh's excellent EFSA and US approval papers. If a few of the much vaunted "growing number of brand owners" would step up to the plate I'd be delighted. Having added a modest amount during the downward push, it's good to see a couple of strong days.